Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

Clinical trial NCT06724835 · UNKNOWN

Trial details

NCT number: NCT06724835
Sponsor: Shenzhen Celconta Life Science Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2024-03-11
Primary completion: 2026-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.